EcCas6e-based antisense crRNA for gene repression and RNA editing in microorganisms
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkae612 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Mutong Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China. Hauptthemen laut MEDLINE: RNA Editing, Saccharomyces cerevisiae, Escherichia coli, RNA, Antisense. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key R&D Program of China, CAMS Innovation Fund for Medical Sciences (CIFMS), National Natural Science Foundation of China.
Abstract (Originalsprache)
Precise gene regulation and programmable RNA editing are vital RNA-level regulatory mechanisms. Gene repression tools grounded in small non-coding RNAs, microRNAs, and CRISPR-dCas proteins, along with RNA editing tools anchored in Adenosine Deaminases acting on RNA (ADARs), have found extensive application in molecular biology and cellular engineering. Here, we introduced a novel approach wherein we developed an EcCas6e mediated crRNA–mRNA annealing system for gene repression in Escherichia coli and RNA editing in Saccharomyces cerevisiae. We found that EcCas6e possesses inherent RNA annealing ability attributed to a secondary positively charged cleft, enhancing crRNA–mRNA hybridization and stability. Based on this, we demonstrated that EcCas6e, along with its cognate crRNA repeat containing a complementary region to the ribosome binding site of a target mRNA, effectively represses gene expression up to 25-fold. Furthermore, we demonstrated that multiple crRNAs can be easily assembled and can simultaneously target up to 13 genes. Lastly, the EcCas6e–crRNA system was developed as an RNA editing tool by fusing it with the ADAR2 deaminase domain. The EcCas6e–crRNA mediated gene repression and RNA editing tools hold broad applications for research and biotechnology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China.
- Key Laboratory of Engineering Biology for Low-Carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China.
- College of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China.
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
- National Center of Technology Innovation for Synthetic Biology, Tianjin 300308, China.
ORCID-Profile: Wenyu Lu, Chaoyou Xue
Förderung
- National Key R&D Program of China
- CAMS Innovation Fund for Medical Sciences (CIFMS)
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences
- Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project
- Haihe Laboratory
Zitieren
APA
Li, M., Cai, Z., Song, S., Yue, X., Lu, W., Rao, S., Zhang, C., & Xue, C. (2024). EcCas6e-based antisense crRNA for gene repression and RNA editing in microorganisms. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae612
Vancouver
Li M, Cai Z, Song S, Yue X, Lu W, Rao S, et al. EcCas6e-based antisense crRNA for gene repression and RNA editing in microorganisms. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae612
BibTeX
@article{Li2024,
author = {Li, Mutong and Cai, Zhaohui and Song, Shucheng and Yue, Xinmin and Lu, Wenyu and Rao, Shuquan and Zhang, Chuanbo and Xue, Chaoyou},
title = {EcCas6e-based antisense crRNA for gene repression and RNA editing in microorganisms},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkae612}
}
EUVIMED